Jade Biosciences, Inc.
JBIONasdaqCIK 1798749HealthcareFiscal year ends Dec 31
Reports and events: 108 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-3007:13 ET | 8-K | 8.01 Other events | 0001193125-26-408287 |
| 2026-08-1007:21 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-341242 |
| 2026-08-1007:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-341229 |
| 2026-07-0116:41 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-292704 |
| 2026-06-2607:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-283906 |
| 2026-06-1116:28 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-267640 |
| 2026-06-0917:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-071942 |
| 2026-06-0417:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-257733 |
| 2026-06-0107:55 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-249763 |
| 2026-05-0716:27 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-212088 |
| 2026-05-0716:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211973 |
| 2026-04-2816:12 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001193125-26-187059 |
| 2026-04-2207:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-168351 |
| 2026-04-0216:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-140091 |
| 2026-03-0616:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-096550 |
| 2026-03-0607:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-094967 |
| 2026-03-0506:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-023732 |
| 2026-01-0507:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-001502 |
| 2025-12-2216:38 ET | S-1 | Registration statement | 0001193125-25-328848 |
| 2025-12-1507:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-318436 |
| 2025-11-1416:09 ET | S-1 | Registration statement | 0001193125-25-282921 |
| 2025-11-1407:13 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-281525 |
| 2025-11-1407:00 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-281498 |
| 2025-10-0816:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-097923 |
| 2025-10-0707:13 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-232562 |
| 2025-09-0907:13 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-198777 |
| 2025-08-1316:20 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001193125-25-179853 |
| 2025-08-1316:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-179828 |
| 2025-07-0107:08 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-153427 |
| 2025-05-1416:12 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-119856 |
| 2025-05-0118:31 ET | SCHEDULE 13D | Ownership report, active investor | 0000950170-25-062146 |
| 2025-05-0116:22 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-110004 |
| 2025-04-3016:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-011581 |
| 2025-04-3016:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-011576 |
| 2025-04-2916:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-103761 |
| 2025-04-2516:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-005564 |
| 2025-04-2316:37 ET | 8-K | 8.01 Other events | 0001558370-25-005278 |
| 2025-04-2108:07 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-036566 |
| 2025-04-0916:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-033397 |
| 2025-04-0907:00 ET | 8-K | 8.01 Other events | 0001104659-25-033200 |
| 2025-04-0708:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-004511 |
| 2025-03-2707:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003750 |
| 2024-11-1216:40 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001798749-24-000059 |
| 2024-10-3109:27 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-112896 |
| 2024-10-1716:59 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001798749-24-000055 |
| 2024-10-1017:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001798749-24-000052 |
| 2024-08-1216:31 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001798749-24-000049 |
| 2024-07-0808:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001798749-24-000042 |
| 2024-07-0116:03 ET | 8-K/A | 2.05 Exit or disposal costs | 0001798749-24-000039 |
| 2024-06-2816:59 ET | 8-K | 2.05 Exit or disposal costs | 0001798749-24-000036 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.